Instead, we opted to produce meta-analysis estimates that are clinically relevant and meaningful by conducting separate analyses based on type of comparator (placebo, GLP-1 RAs and basal insulin) for each outcome
Study limitations include presence of statistical heterogeneity in the meta-analyses for change in HbA 1c and body weight, assessment of risk of bias solely for the primary outcome, and generalisation of findings mainly to individuals who are overweight or obese and already on metformin-based background therapy
Evidence Summaries and Recommendations From the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome: Lifestyle Management
Myasoedova, E., Crowson, C
to create both visible and sustainable results
Addressing pelvic inflammatory drivers like endometriosis when gut symptoms are refractory